Related Experiment Video
Updated: Jul 3, 2026
09:14
Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens
Published on: June 28, 2018
Meeting review: 2002 O'Reilly Bioinformatics Technology Conference
1MRC UK Human Genome Mapping Project Resource Centre, Hinxton, Cambridge CB10 1SB, UK. d.counsell@hgmp.mrc.ac.uk
Comparative and Functional Genomics
|July 17, 2008
Summary
The first O'Reilly Bioinformatics Technology Conference brought together experts in biological and computational sciences. This event showcased a new, interdisciplinary meeting style that may become standard for future scientific conferences.
Area of Science:
- Bioinformatics
- Computational Biology
- Life Sciences Technology
Background:
- The O'Reilly Bioinformatics Technology Conference represents a novel format for scientific meetings.
- The conference aimed to bridge the gap between biological and computational sciences.
Purpose of the Study:
- To report on the inaugural O'Reilly Bioinformatics Technology Conference.
- To highlight the unique structure and diverse participation of the conference.
- To suggest the potential future impact of this meeting style on scientific conferences.
Main Methods:
- Attendance and participation in the O'Reilly Bioinformatics Technology Conference.
- Observation of presentations, tutorials, and debates.
- Engagement with a diverse group of researchers, programmers, and publishers.
Main Results:
- The conference was large, well-organized, and featured diverse attendees.
- Prominent figures from bioinformatics, open-source programming, and publishing were present.
- The event included a variety of formats, from technical presentations to a "jam session" for bioinformaticists.
Conclusions:
- The O'Reilly Bioinformatics Technology Conference adopted a non-traditional, interdisciplinary format.
- This meeting style is likely to influence the future of conferences in biological and computational sciences.
Related Concept Videos
01:20Biostatistics: Overview
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Discrete variables are...
02:34DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
02:24Ribosome Profiling
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
01:16Bioequivalence: Overview
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
03:36Genome Annotation and Assembly
The genome refers to all of the genetic material in an organism. It can range from a few million base pairs in microbial cells to several billion base pairs in many eukaryotic organisms. Genome assembly refers to the process of taking the DNA sequencing data and putting it all back together in a correct order to create a close representation of the original genome. This is followed by the identification of functional elements on the newly assembled genome, a process called genome annotation.
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.